Zafar Ali Khan*, Anwar Ali**, Riaz Ahmed Warraich***
Post Graduate Resident, Dept of Oral & Maxillofacial Surgery, King Edward Medical University & Mayo Hospital, Lahore.
Assistant Professor, Dept of Oral & Maxillofacial Surgery, Dr. Ishrat-ul-Ibad Institute of Oral & Health Sciences, Karachi
Professor, Oral & Maxillofacial Surgery, King Edward Medical University & Mayo Hospital, Lahore.
Correspondence: “Dr. Anwar Ali”
Volume 19, Issue 2 (April - June 2010)
Trigeminal neuralgia is an idiopathic, paroxysmal, painful, unilateral affliction of the face, evoked by trivial stimuli to the specific trigger zone, lasting from a few seconds to two minutes. Medical and surgical treatment options are available with varying degree of efficacy. The objective of the study is to compare the analgesic effects of streptomycin/bupivacain versus anhydrous glycerol injection in trigeminal neuralgia.
Sixty patients were selected via Non- probability, purposive sampling technique, at the department of oral and maxillofacial surgery, king Edward Medical University/Mayo Hospital Lahore, from 1st June 2008 to 30th Nov 2008. Patients were randomly distributed in to 2 equal groups. In Group A streptomycin/bupvivacain injection was administered, in Group B 1ml anhydrous glycerol injection was administered. Patients were reviewed after one week, one month, three month and six months post operatively.
25(83.34%) patients of Group A had excellent pain relief, 03(10%) had good results and 02(6.66%) patients had poor results. 28(93.34%) patients of Group B had excellent results, and 2(6.66%) patients had good results while none of the patients had poor results. The p value for these two procedures is not significant (p=0.378).
The analgesic effect of streptomycin/bupvivacain injection is same as glycerol injection in trigeminal neuralgia. They are simple, quick, and easy to perform, and can be used as outpatient procedures.
Trigeminal neuralgia, anhydrous glycerol, streptomycin, Visual analogue scale.
How to CITE:
J Pak Dent Assoc 2010;19(2):99-104.